衞寧健康(300253.SZ):2024年上半年公司醫療衞生信息化業務新簽訂單合同金額同比保持增長
格隆匯7月18日丨衞寧健康(300253.SZ)在投資者互動平台表示,2024年上半年公司醫療衞生信息化業務新簽訂單合同金額同比保持增長。之前回復過,公司認為醫療信息化行業景氣度在上升。公司2023年報第10頁對醫療軟件行業市場規模和發展趨勢有詳細介紹:2023年3月,IDC發佈的《中國醫療軟件系統解決方案市場預測,2023—2027》研究報吿預測:醫院應用軟件系統市場方面,從2023年開始,市場將會恢復增長,未來五年中都將保持比較穩定的高速增長,預計到2027年市場規模將達到347.9億元,2022至2027年的年複合增長率為18.2%;區域衞生信息平台及應用軟件系統解決方案方面,從2023年開始在《“十四五”全民健康信息化規劃》的促進下,該市場將會加速增長,預計到2027年市場規模將達到110.9億元,2022至2027年的年複合增長率為19.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.